Torcetrapib and coronary events.
Cohn
Lawrence J
LJ
D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069059:Atorvastatin; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D011758:Pyrroles / Q000627:therapeutic use; D011804:Quinolines / Q000009:adverse effects*; D017211:Treatment Failure
D000924:Anticholesteremic Agents; D053480:Cholesterol Ester Transfer Proteins; D006538:Heptanoic Acids; D011758:Pyrroles; D011804:Quinolines; C483909:torcetrapib; D000069059:Atorvastatin